TPTX News and Press, Turning Point Therapeutics Inc. From 05/30/20

Over the past week, the S&P 500 rose again by 2.75%, almost recovering from its YTD losses. With economies restarting, novel optimism about vaccines and better-than-feared job losses last week, the stock market is behaving very optimistically. Of course, the biggest reason for this strong ...

SAN DIEGO, May 29, 2020 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today at the ASCO Annual Meeting presented a preclinical update for its novel, clinical-stage...

SAN DIEGO, May 27, 2020 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (Nasdaq: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced that the underwriters of its previously announced underwritten public offerin...

Gamida Cell (NASDAQ: GMDA )  -25%  after pricing equity offering. More news on: Gamida Cell Ltd., Gossamer Bio, Inc., Bellerophon Therapeutics, Inc., Stocks on the move, , Read more ...

Turning Point Therapeutics (NASDAQ: TPTX ) has priced its public offering of 5,416,667 common shares at $60.00/share, for expected gross proceeds of ~$325M. More news on: Turning Point Therapeutics, Inc., Healthcare stocks news, , Read more ...

SAN DIEGO, May 18, 2020 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (Nasdaq: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced the pricing of its previously announced underwritten public offering of 5,416...

Turning Point Therapeutics (NASDAQ: TPTX ) has commenced a public offering to issue and sell $250M shares of common stock. More news on: Turning Point Therapeutics, Inc., Healthcare stocks news, , Read more ...

The following slide deck was published by Turning Point Therapeutics, Inc. in conjunction with their 2020 Q1 earnings Read more ...

Image source: The Motley Fool. Turning Point Therapeutics Inc   (NASDAQ: TPTX) Q1 2020 Earnings Call May 12, 2020 , 4:30 p.m. ET Operator Continue reading

Turning Point Therapeutics, Inc. (TPTX) Q1 2020 Earnings Conference Call May 12, 2020 4:30 p.m. ET Company Participants Jim Mazzola - SVP, Communication and IR Athena Countouriotis - President and CEO Yi Larson - EVP and CFO Conference Call Participants Corinne Jenkins - Go...